{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:47:00Z","timestamp":1776523620492,"version":"3.51.2"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jneuroim.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T02:45:19Z","timestamp":1460515519000},"page":"18-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes"],"prefix":"10.1016","volume":"295-296","author":[{"given":"Benjamin","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Stich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Labeit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Rauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2016.04.004_bb0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.1990.tb05440.x","article-title":"Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin","volume":"82","author":"Aarli","year":"1990","journal-title":"Clin. Exp. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2016.04.004_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2015.03.027","article-title":"\u201cNon-classical\u201d paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to \u201cclassical\u201d syndromes \u2014 more frequent than expected","volume":"352","author":"Berger","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jneuroim.2016.04.004_bb0015","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jneuroim.2016.04.004_bb0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00415-004-0479-z","article-title":"The significance of titin antibodies in myasthenia gravis","volume":"251","author":"Chen","year":"2004","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2016.04.004_bb0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.43.8.1581","article-title":"Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin","volume":"43","author":"Gautel","year":"1993","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jneuroim.2016.04.004_bb0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jneuroim.2016.04.004_bb0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ijc.22384","article-title":"Mitofilin and titin as target antigens in melanoma-associated retinopathy","volume":"120","author":"Pf\u00f6hler","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.jneuroim.2016.04.004_bb0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.04.004_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1254.039","article-title":"Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies","volume":"998","author":"Skeie","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2016.04.004_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.59.1.92","article-title":"The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970\u20131999","volume":"59","author":"Somnier","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2016.04.004_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1468-1331.1999.650555.x","article-title":"EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis","volume":"6","author":"Somnier","year":"1999","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.04.004_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2016.01.018","article-title":"Titin antibodies in \u201cseronegative\u201d myasthenia gravis \u2014 a new role for an old antigen","volume":"292","author":"Stergiou","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2016.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/archneurol.2009.229","article-title":"Autoimmune targets of heart and skeletal muscles in myasthenia gravis","volume":"66","author":"Suzuki","year":"2009","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2016.04.004_bb0070","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.49.5.1454","article-title":"Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor","volume":"49","author":"Voltz","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2016.04.004_bb0075","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bjd.13525","article-title":"Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Dermatol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:09Z","timestamp":1759048029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816300741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":15,"alternative-id":["S0165572816300741"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.04.004","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}